These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38914609)

  • 1. In silico analysis unveiling potential biomarkers in gallbladder carcinogenesis.
    Gupta RK; Bhushan R; Kumar S; Prasad SB
    Sci Rep; 2024 Jun; 14(1):14570. PubMed ID: 38914609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 3. Microarray based gene expression profiling of advanced gall bladder cancer.
    Kumar A; Gupta R; Mathur N; Iyer VK; Thulkar S; Prasad CP; Das P; Rani L; Maqbool M; Shukla NK; Pal S; Sundar D; Sharma A
    Exp Oncol; 2020 Dec; 42(4):277-284. PubMed ID: 33355862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA aberrations: An emerging field for gallbladder cancer management.
    Chandra V; Kim JJ; Mittal B; Rai R
    World J Gastroenterol; 2016 Feb; 22(5):1787-99. PubMed ID: 26855538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of microRNAs associated with the survival of patients with gallbladder carcinoma.
    Wang J; Jin Y; Li S; Song Q; Tang P
    J Int Med Res; 2020 May; 48(5):300060520918061. PubMed ID: 32406793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unveiling Potential Targeted Therapeutic Opportunities for Co-Overexpressed Targeting Protein for Xklp2 and Aurora-A Kinase in Lung Adenocarcinoma.
    Mukherjee A; Yadav PH; Mukunthan KS
    Mol Biotechnol; 2024 Oct; 66(10):2792-2803. PubMed ID: 37768502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1.
    Khedkar HN; Wang YC; Yadav VK; Srivastava P; Lawal B; Mokgautsi N; Sumitra MR; Wu ATH; Huang HS
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of characteristic genes and construction of regulatory network in gallbladder carcinoma.
    Shao H; Zhu J; Zhu Y; Liu L; Zhao S; Kang Q; Liu Y; Zou H
    BMC Med Genomics; 2023 Oct; 16(1):240. PubMed ID: 37821907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four novel biomarkers for bladder cancer identified by weighted gene coexpression network analysis.
    Yan X; Guo ZX; Liu XP; Feng YJ; Zhao YJ; Liu TZ; Li S
    J Cell Physiol; 2019 Aug; 234(10):19073-19087. PubMed ID: 30927274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma.
    Gu X; Li B; Jiang M; Fang M; Ji J; Wang A; Wang M; Jiang X; Gao C
    Oncotarget; 2015 Aug; 6(24):20661-71. PubMed ID: 25970782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.
    Alvarez H; Corvalan A; Roa JC; Argani P; Murillo F; Edwards J; Beaty R; Feldmann G; Hong SM; Mullendore M; Roa I; Ibañez L; Pimentel F; Diaz A; Riggins GJ; Maitra A
    Clin Cancer Res; 2008 May; 14(9):2631-8. PubMed ID: 18451226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KNTC1 and MCM2 are the molecular targets of gallbladder cancer.
    Jia W; Wang C
    Aging (Albany NY); 2023 Jul; 15(14):7008-7022. PubMed ID: 37480569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling.
    Qin Y; Meng L; Fu Y; Quan Z; Ma M; Weng M; Zhang Z; Gao C; Shi X; Han K
    Oncotarget; 2017 Mar; 8(12):19980-19996. PubMed ID: 28212545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eukaryotic translation initiation factor 6 overexpression plays a major role in the translational control of gallbladder cancer.
    Golob-Schwarzl N; Wodlej C; Kleinegger F; Gogg-Kamerer M; Birkl-Toeglhofer AM; Petzold J; Aigelsreiter A; Thalhammer M; Park YN; Haybaeck J
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2699-2711. PubMed ID: 31586263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis.
    Hu YP; Jin YP; Wu XS; Yang Y; Li YS; Li HF; Xiang SS; Song XL; Jiang L; Zhang YJ; Huang W; Chen SL; Liu FT; Chen C; Zhu Q; Chen HZ; Shao R; Liu YB
    Mol Cancer; 2019 Nov; 18(1):167. PubMed ID: 31752906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p.
    Goeppert B; Truckenmueller F; Ori A; Fritz V; Albrecht T; Fraas A; Scherer D; Silos RG; Sticht C; Gretz N; Mehrabi A; Bewerunge-Hudler M; Pusch S; Bermejo JL; Dietrich P; Schirmacher P; Renner M; Roessler S
    Sci Rep; 2019 Mar; 9(1):4796. PubMed ID: 30886199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput screening identified miR-7-2-3p and miR-29c-3p as metastasis suppressors in gallbladder carcinoma.
    Lu K; Feng F; Yang Y; Liu K; Duan J; Liu H; Yang J; Wu M; Liu C; Chang Y
    J Gastroenterol; 2020 Jan; 55(1):51-66. PubMed ID: 31562534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine.
    Yang C; Xu M; Shen HJ; Zhu HY; Li F; He M; Chen T; Wang J; Shi WJ; Ji F
    Int J Clin Exp Pathol; 2014; 7(2):521-8. PubMed ID: 24551272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
    Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
    Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer.
    Zhang M; Gong W; Zuo B; Chu B; Tang Z; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Ma M; Jiang A; Ma F; Quan Z
    Oncotarget; 2016 Nov; 7(48):78640-78652. PubMed ID: 27769047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.